Denali Therapeutics Inc. (DNLI): SCHEDULE 13G/A filed Aug 4, 2026

Form type

SCHEDULE 13G/A

Filing date

Aug 4, 2026

Accession number

0001088875-26-000056

Filer

Denali Therapeutics Inc. (CIK 1714899)